105618-02-8, Galamustine,
CAS:105618-02-8
C10H19Cl2NO5 / 304.168
MFCD00866287
Galamustine is a galactose mustard compound, an alkylating agent, with antineoplastic activity.
Galamustine is a slow-release, viscoelastic formulation of a cytotoxic anticancer drug. It is a microsphere formulation that contains fatty acids and organic acid-soluble polylactic acid. This formulation releases the drug in the stomach and intestine where it binds to lipids and slowly enters the bloodstream. The drug has been shown to inhibit tumor growth by binding to the enzyme inhibitors at the active site of an enzyme that regulates cell division. Galamustine has also been shown to have anti-cancer activity in animal models through inhibition of protein synthesis and induction of apoptosis in cancer cells.
CAS Number | 105618-02-8 |
Product Name | Galamustine |
IUPAC Name | (3R,4S,5R,6R)-6-[bis(2-chloroethyl)aminomethyl]oxane-2,3,4,5-tetrol |
Molecular Formula | C10H19Cl2NO5 |
Molecular Weight | 304.168 g/mol |
InChI | InChI=1S/C10H19Cl2NO5/c11-1-3-13(4-2-12)5-6-7(14)8(15)9(16)10(17)18-6/h6-10,14-17H,1-5H2/t6-,7+,8+,9-,10?/m1/s1 |
InChI Key | COKGUJJIBXWRNV-CYNREMDZSA-N |
SMILES | C(CCl)N(CCCl)CC1C(C(C(C(O1)O)O)O)O |
Synonyms | 6-(bis(2-chloroethyl)amino)-6-deoxygalactopyranose, 6-bis-(2-chloroethyl)amino-6-deoxygalactopyranose, C6-galactose mustard, C6-galactose mustard hydrochloride, C6-GLM, galactose-6-mustard |
Canonical SMILES | C(CCl)N(CCCl)CC1C(C(C(C(O1)O)O)O)O |
Isomeric SMILES | C(CCl)N(CCCl)C[C@@H]1[C@@H]([C@@H]([C@H](C(O1)O)O)O)O |
Contact: Miss.Xing
Phone: 18310328607 , 13621067991,13552979007
Tel: 86+10-61274189
Email: chemsynlab@163.com, zhangchao@chemsynlab.com
Add: A411 Room,No.26,Jinyuan Road,Daxing Industrial Developing District,Beijing,China post code:102628